XML 19 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Conversion of Series F Preferred Stock into Common Stock [Member]
Conversion Of Series C-1 And D-1 Preferred Stock Into Common Stock [Member]
Preferred Stock [Member]
Series C-1 Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series C-1 Convertible Preferred Stock [Member]
Conversion Of Series C-1 And D-1 Preferred Stock Into Common Stock [Member]
Preferred Stock [Member]
Series F Convertible Preferred Stock [Member]
Preferred Stock [Member]
Series F Convertible Preferred Stock [Member]
Conversion of Series F Preferred Stock into Common Stock [Member]
Common Stock [Member]
Common Stock [Member]
Conversion of Series F Preferred Stock into Common Stock [Member]
Common Stock [Member]
Conversion Of Series C-1 And D-1 Preferred Stock Into Common Stock [Member]
Common Stock [Member]
Series C-1 Convertible Preferred Stock [Member]
Common Stock [Member]
Series F Convertible Preferred Stock [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Conversion of Series F Preferred Stock into Common Stock [Member]
Additional Paid-in Capital [Member]
Conversion Of Series C-1 And D-1 Preferred Stock Into Common Stock [Member]
Retained Earnings [Member]
Beginning Balance (in shares) at Dec. 31, 2014       4,000   3,000   15,226,000                
Beginning Balance at Dec. 31, 2014 $ 48,456     $ 3,917   $ 2,798   $ 2         $ 528,353     $ (486,614)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock issued during period (in shares)               2,933,000     19,134 17,360        
Stock issued during period, value 104,596                       104,596      
Conversion of Convertible Preferred Stock into common stock   $ 0 $ 0   $ (11)   $ (61)             $ 61 $ 11  
Conversion of Convertible Preferred Stock into common stock (in shares)                 17,000 19,000            
Share-based compensation expense 11,551                       11,551      
Third party share-based compensation expense $ 1,521                       1,521      
Exercise of stock options for common stock (in shares) 51,814             45,000                
Exercise of stock options for common stock $ 315                       315      
Issuance of restricted stock awards (in shares)               4,000                
Issuance of restricted stock awards 0                              
Net loss (41,912)                             (41,912)
Ending Balance (in shares) at Dec. 31, 2015       4,000   3,000   18,244,000                
Ending Balance at Dec. 31, 2015 124,527     $ 3,906   $ 2,737   $ 2         646,408     (528,526)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Share-based compensation expense 14,349                       14,349      
Third party share-based compensation expense $ 197                       197      
Exercise of stock options for common stock (in shares) 17,548             17,000                
Exercise of stock options for common stock $ 149                       149      
Net loss (78,185)                             (78,185)
Ending Balance (in shares) at Dec. 31, 2016       4,000   3,000   18,261,000                
Ending Balance at Dec. 31, 2016 61,037     $ 3,906   $ 2,737   $ 2         661,103     (606,711)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock issued during period (in shares)               3,731,000                
Stock issued during period, value 117,480                       117,480      
Share-based compensation expense 20,776                       20,776      
Third party share-based compensation expense $ 1,019                       1,019      
Exercise of stock options for common stock (in shares) 174,628             175,000                
Exercise of stock options for common stock $ 2,693                       2,693      
Net loss (114,803)                             (114,803)
Ending Balance (in shares) at Dec. 31, 2017       4,000   3,000   22,167,000                
Ending Balance at Dec. 31, 2017 $ 88,202     $ 3,906   $ 2,737   $ 2         $ 803,071     $ (721,514)